Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-14 Sale(A) |
2022-03-15 7:12 pm |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
63,340 | $0.31 | $19,635 | 65,292 (Direct) |
View |
| 2022-03-14 Sale |
2022-03-15 5:01 pm |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
47,132 | $0.38 | $17,910 | 181,500 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-12 8:22 pm |
Iterum Therapeutics plc | ITRM | DENNER ALEXANDER J Sarissa Capital Management LP Sarissa Capital Offshore Master Fund LP Sarissa Capital Catapult Fund LLC Sarissa Capital Hawkeye Fund LP Sarissa Capital Master Fund II LP 10% Owner |
20,619,949 | $2.4252 | $50,007,284 | 0 (Indirect) |
View |
| 2021-01-26 Sale |
2021-01-27 7:35 pm |
Iterum Therapeutics plc | ITRM | Fishman Corey N. President & CEO |
85,445 | $1.73 | $147,820 | 322,008 (Direct) |
View |
| 2021-01-26 Sale |
2021-01-27 7:32 pm |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
33,143 | $1.73 | $57,337 | 256,355 (Direct) |
View |
| 2021-01-26 Sale |
2021-01-27 7:32 pm |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
33,868 | $1.73 | $58,592 | 28,632 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-25 Option Award |
2022-06-28 9:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | HUNT RONALD Director |
30,623 | $0 | 30,623 (Direct) |
View |
| 2022-06-25 Option Award |
2022-06-28 9:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
19,488 | $0 | 19,488 (Direct) |
View |
| 2022-06-23 Exercise |
2022-06-24 6:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | HUNT RONALD Director |
36,798 | $0 | 1,498,804 (Direct) |
View |
| 2022-06-23 Exercise |
2022-06-24 6:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Chin Mark Director |
36,798 | $0 | 36,798 (Direct) |
View |
| 2022-06-23 Exercise |
2022-06-24 6:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
36,798 | $0 | 383,647 (Direct) |
View |
| 2022-06-23 Exercise |
2022-06-24 6:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
36,798 | $0 | 44,805 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:02 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
237,795 | $0.01 | 237,795 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:01 pm |
N/A 2032-06-14 |
Iterum Therapeutics plc | ITRM | Kelly David George Director |
647,059 | $0 | 647,059 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:01 pm |
N/A 2032-06-14 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
647,059 | $0 | 647,059 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:01 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Chin Mark Director |
237,795 | $0.01 | 237,795 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
237,795 | $0 | 237,795 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:00 pm |
N/A 2032-06-14 |
Iterum Therapeutics plc | ITRM | HUNT RONALD Director |
647,059 | $0.01 | 647,059 (Direct) |
View |
| 2022-03-25 Option Award |
2022-03-29 8:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | HUNT RONALD Director |
17,955 | $0 | 17,955 (Direct) |
View |
| 2022-03-25 Option Award |
2022-03-29 8:00 pm |
N/A 2032-03-26 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
47,436 | $0 | 47,436 (Direct) |
View |
| 2022-03-25 Option Award |
2022-03-29 8:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
11,426 | $0 | 358,275 (Direct) |
View |
| 2022-03-25 Exercise |
2022-03-29 8:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
10,494 | $0 | 358,275 (Direct) |
View |
| 2022-03-18 Exercise |
2022-03-22 7:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
7,642 | $0 | 8,007 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-15 5:01 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
100,000 | $0 | 181,500 (Direct) |
View |
| 2022-03-11 Exercise |
2022-03-15 5:01 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
100,000 | $0 | 181,500 (Direct) |
View |
| 2022-03-11 Exercise |
2022-03-15 5:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Fishman Corey N. Chief Executive Officer |
215,000 | $0 | 752,008 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 5:00 pm |
N/A 2031-12-09 |
Iterum Therapeutics plc | ITRM | Puttagunta Sailaja Chief Medical Officer |
2,300,000 | $0 | 2,300,000 (Direct) |
View |
| 2021-07-25 Option Award |
2021-07-27 9:30 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
80,000 | $0 | 336,355 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:06 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Chin Mark Director |
36,798 | $0 | 36,798 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:06 pm |
N/A 2031-06-22 |
Iterum Therapeutics plc | ITRM | Kelly David George Director |
64,706 | $0 | 64,706 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:06 pm |
N/A 2031-06-22 |
Iterum Therapeutics plc | ITRM | Fishman Corey N. Chief Executive Officer |
5,280,000 | $0 | 5,280,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:05 pm |
N/A 2031-06-22 |
Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director |
64,706 | $0 | 64,706 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:05 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
36,798 | $0 | 36,798 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:05 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | HUNT RONALD Director |
36,798 | $0 | 36,798 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:05 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
36,798 | $0 | 36,798 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:05 pm |
N/A 2031-06-22 |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
1,936,000 | $0 | 1,936,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 5:33 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
10,494 | $0 | 10,494 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-19 4:30 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Hecht Beth Director |
7,642 | $0 | 7,642 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 4:30 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 4:30 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Fishman Corey N. President & CEO |
430,000 | $0 | 430,000 (Direct) |
View |
| 2020-07-28 Other |
2021-03-03 5:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Chin Mark Director |
11,857 | $0 | 11,857 (Direct) |
View |
| 2021-02-11 Conversion |
2021-02-12 8:22 pm |
2021-01-21 2025-01-31 |
Iterum Therapeutics plc | ITRM | DENNER ALEXANDER J Sarissa Capital Management LP Sarissa Capital Offshore Master Fund LP Sarissa Capital Catapult Fund LLC Sarissa Capital Hawkeye Fund LP Sarissa Capital Master Fund II LP 10% Owner |
35,619,949 | $0 | 0 (Indirect) |
View |
| 2021-02-04 Conversion |
2021-02-08 5:22 pm |
2021-01-21 2025-01-31 |
Iterum Therapeutics plc | ITRM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
20,137,597 | $0 | 11,651,597 (Indirect) |
View |
| 2021-01-25 Option Award |
2021-01-27 7:35 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Fishman Corey N. President & CEO |
167,500 | $0 | 322,008 (Direct) |
View |
| 2021-01-25 Option Award |
2021-01-27 7:32 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Dunne Michael W. Director |
80,000 | $0 | 256,355 (Direct) |
View |
| 2021-01-25 Option Award |
2021-01-27 7:32 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
62,500 | $0 | 28,632 (Direct) |
View |